Beijing Aosaikang Pharmaceutical Co Ltd
SZSE:002755
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Beijing Aosaikang Pharmaceutical Co Ltd
SZSE:002755
|
CN |
|
Loyaltypoint Inc
OTC:LYLP
|
US |
|
Suzhou Huaya Intelligence Technology Co Ltd
SZSE:003043
|
CN |
|
Greenway Technologies Inc
OTC:GWTI
|
US |
|
I
|
Israel Canada TR Ltd
TASE:ISCN
|
IL |
|
HyPower Fuel Inc
OTC:HYPF
|
CA |
|
Olive Tree Estates Ltd
SGX:1H2
|
SG |
|
Z
|
Zhejiang TongLi Transmission Technology Co Ltd
SZSE:301255
|
CN |
|
N
|
Network International Holdings PLC
OTC:NWKLF
|
AE |
|
M
|
M8 Sustainable Ltd
ASX:M8S
|
AU |
|
ITE (Holdings) Ltd
HKEX:8092
|
HK |
|
Investco Corp
OTC:IVCO
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Beijing Aosaikang Pharmaceutical Co Ltd's stock price target?
Not Available
Beijing Aosaikang Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Beijing Aosaikang Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
17%
For the last 11 years the
compound annual growth rate for
Beijing Aosaikang Pharmaceutical Co Ltd's revenue is
12%.
The projected
CAGR
for the next 2 years is
17%.
What is Beijing Aosaikang Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
47%
For the last 11 years the
compound annual growth rate for
Beijing Aosaikang Pharmaceutical Co Ltd's operating income is
5%.
The projected
CAGR
for the next 2 years is
47%.
What is Beijing Aosaikang Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
23%
For the last 11 years the
compound annual growth rate for
Beijing Aosaikang Pharmaceutical Co Ltd's net income is
10%.
The projected
CAGR
for the next 2 years is
23%.
